Afinida, Inc.
TREP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $2 | $7 |
| - Cash | $3 | $2 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $4 |
| Enterprise Value | -$1 | $0 | $2 | $11 |
| Revenue | $23 | $18 | $18 | $18 |
| % Growth | 25.5% | 0% | 4.2% | – |
| Gross Profit | $15 | $12 | $14 | $9 |
| % Margin | 64.5% | 66.6% | 75.1% | 52.9% |
| EBITDA | $2 | $2 | $4 | $2 |
| % Margin | 7.7% | 8.5% | 20.3% | 10.3% |
| Net Income | $1 | $2 | $2 | $2 |
| % Margin | 5.7% | 8.5% | 8.3% | 9.4% |
| EPS Diluted | 0.023 | 0.028 | 0.054 | 0.031 |
| % Growth | -16.2% | -48% | 72% | – |
| Operating Cash Flow | $1 | -$14 | $2 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$14 | $2 | $2 |